close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Pure-Play Quantum Computing Stocks Are Up 24% MTD - Here's Why
Via Talk Markets
Ivonescimab with Chemotherapy Reduced the Risk of Disease Progression or Death by 40% Compared to Tislelizumab (PD-1 Inhibitor) Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in China
From Summit Therapeutics
Via Business Wire
Tickers SMMT
Kessler Topaz Meltzer &amp; Check, LLP Notifies Fortinet, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers FTNT
Exposures Financial Legal
Kessler Topaz Meltzer & Check, LLP Notifies Fortinet, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
Tickers FTNT
Exposures Financial Legal
MOH REMINDER: Kessler Topaz Meltzer & Check, LLP Urges MOH Investors With Losses to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Tickers MOH
Exposures Financial Legal
MOH REMINDER: Kessler Topaz Meltzer &amp; Check, LLP Urges MOH Investors With Losses to Contact the Firm
Via TheNewswire.com
Topics Lawsuit
Tickers MOH
Exposures Financial Legal
What Is One of the Best Quantum Computing Stocks to Buy Now?
Via The Motley Fool
Tickers QBTS
Weekend Round-Up: AI Takes Center Stage As Nvidia, Microsoft, Blackrock, Intel And Apple Make Big Moves
Via Benzinga
Topics Artificial Intelligence
Tickers AAPL BLK INTC JPM MSFT NVDA
Exposures Artificial Intelligence
Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION® Platform at the European Society of Medical Oncology Annual Congress
From AVACTA GROUP PLC
Via GlobeNewswire
Tickers LSE
Social Security Benefits Aren't Enough to Live On. The 2026 Raise Won't Change That.
Via The Motley Fool
Topics Economy Retirement
Exposures Interest Rates Pension
Earnings And Volatility Will Lead To Ideal Setups
Via Talk Markets
Range Financial Dumps Nearly 30,000 Fortinet Shares for $3.2 Million
Via The Motley Fool
Topics Regulatory Compliance
Tickers FTNT NVDA STX
Exposures Legal Regulatory
Could Investing $10,000 in Coca-Cola Help Make You a Millionaire?
Via The Motley Fool
Tickers BRK-A BRK-B KO
The New Nuclear Arms Race: Inside America’s Rush For Uranium Security
Via Talk Markets
Bitcoin Briefly Slips Below $105,000. Is It Time to Buy?
Via The Motley Fool
Topics ETFs World Trade
Exposures Tariff
Weekend Round-Up: Ripple's $1 Billion Fundraise, Bitcoin's Bold Predictions And Crypto's Political Champions
Via Benzinga
Why I Keep Buying More Shares of This Amazing 5.8%-Yielding Dividend Stock
Via The Motley Fool
Topics Economy Government World Trade
Tickers ENB
Exposures Economy Fossil Fuels Interest Rates
The Trump Boom: A Legend In His Own Mind
Via Talk Markets
Topics Government
Exposures Political
The Best Small-Cap Stock ETF to Invest $100 in Right Now Is the Avantis U.S. Small Cap Value ETF (AVUV)
Via The Motley Fool
Topics ETFs Stocks
Tickers AVUV
Exposures US Equities
IonQ, Tempus AI And AeroVironment Are Among Top 10 Large Cap Losers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio?
Via Benzinga
Topics Artificial Intelligence
Tickers ALAB AVAV DRS FFIV FHN IONQ
Exposures Artificial Intelligence
3 Dividend Stocks That Could Pay Retirees Steady Income for Decades
Via The Motley Fool
Topics World Trade
Tickers EPD MO PEP PM
Exposures Tariff
Prediction: This Unstoppable Vanguard ETF Will Beat the S&P 500 Yet Again in 2026
Via The Motley Fool
Topics ETFs Stocks
Tickers AAPL AMZN AVGO MSFT NVDA TSLA
Exposures US Equities
The Insider Report: Are Bears Getting Ready to Hibernate?
Via Benzinga
Tickers BBAI CLSK NET
D-Wave Quantum, Estee Lauder, and Bunge Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio?
Via Benzinga
Tickers ACI BE BG EL JBHT KEP
Innovation Rooted in Listening: Relaxure Custom Pergolas Bring Smart Comfort to Every Home
Via ACCESS Newswire
DS-3939 Shows Promising Preliminary Clinical Activity in Patients with Advanced Solid Tumors in Phase 1/2 Trial
From Daiichi Sankyo
Via Business Wire
WTI Crude Oil Weekly Forecast: Another Downturn After Early Speculative Buys
Via Talk Markets
Exposures Fossil Fuels
Nuclear Stocks, Rare Earth Minerals & Uranium
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Will All Social Security Retirees Get a Benefits Increase in 2026?
Via The Motley Fool
Topics Economy Retirement
Exposures Interest Rates Pension
Raludotatug Deruxtecan Demonstrated Clinically Meaningful Response Rates in Patients with Recurrent Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer in Phase 2 Part of REJOICE-Ovarian01 Phase 2/3 Trial
From Daiichi Sankyo
Via Business Wire
Tickers MRK
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today